应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03692 翰森制药
未开盘 07-22 16:08:56
17.780
+0.500
+2.89%
最高
18.000
最低
17.360
成交量
299.22万
今开
17.500
昨收
17.280
日振幅
3.70%
总市值
1,055亿
流通市值
1,055亿
总股本
59.36亿
成交额
5,303万
换手率
0.05%
流通股本
59.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 翰森制药(03692)涨逾3% 阿美乐肺癌辅助治疗适应症国内上市申请获受理
智通财经 · 07-22 11:11
港股异动 | 翰森制药(03692)涨逾3% 阿美乐肺癌辅助治疗适应症国内上市申请获受理
翰森制药(03692):阿美乐®用于EGFR突变阳性辅助治疗非小细胞肺癌上市许可申请获国家药品监督管理局受理
智通财经 · 07-19
翰森制药(03692):阿美乐®用于EGFR突变阳性辅助治疗非小细胞肺癌上市许可申请获国家药品监督管理局受理
翰森制药(03692.HK):阿美乐用于辅助治疗非小细胞肺癌上市许可申请获受理
阿斯达克财经 · 07-19
翰森制药(03692.HK):阿美乐用于辅助治疗非小细胞肺癌上市许可申请获受理
翰森制药07月19日主力资金流出172万元 连续3日减仓
自选股智能写手 · 07-19
翰森制药07月19日主力资金流出172万元 连续3日减仓
翰森制药07月18日遭主力抛售239万元 环比增加895.83%
自选股智能写手 · 07-18
翰森制药07月18日遭主力抛售239万元 环比增加895.83%
南向资金7月16日净买入翰森制药100.00万股 连续3日增持
自选股智能写手 · 07-17
南向资金7月16日净买入翰森制药100.00万股 连续3日增持
翰森制药(03692)出现大手成交130万股,成交价$16.55,涉资2.152千万
阿斯达克财经 · 07-16
翰森制药(03692)出现大手成交130万股,成交价$16.55,涉资2.152千万
翰森制药(03692)下跌5.17%,报15.78元/股
金融界 · 07-08
翰森制药(03692)下跌5.17%,报15.78元/股
翰森制药盘中异动 股价大跌5.17%
自选股智能写手 · 07-08
翰森制药盘中异动 股价大跌5.17%
翰森制药07月02日遭主力抛售106万元 环比增加1666.67%
自选股智能写手 · 07-02
翰森制药07月02日遭主力抛售106万元 环比增加1666.67%
翰森制药(03692)根据获采纳首次公开发售后受限制股份单位计划授出合共代表1139.76万股的受限制股份单位
智通财经网 · 06-27
翰森制药(03692)根据获采纳首次公开发售后受限制股份单位计划授出合共代表1139.76万股的受限制股份单位
更新版 1-诺和诺德的司美格鲁肽在中国获准“名正言顺”用来减肥,A股概念股逆市上扬
Reuters · 06-25
更新版 1-诺和诺德的司美格鲁肽在中国获准“名正言顺”用来减肥,A股概念股逆市上扬
港股估值性价比凸显,恒生港股通ETF(159318)跟踪指数大幅上涨,蒙牛乳业、翰森制药、龙湖集团领涨。
有连云 · 06-25
港股估值性价比凸显,恒生港股通ETF(159318)跟踪指数大幅上涨,蒙牛乳业、翰森制药、龙湖集团领涨。
创新药板块催化频出,港股创新药ETF(159567)跟踪指数走势较强,云顶新耀-B、来凯医药-B、翰森制药领涨。
有连云 · 06-25
创新药板块催化频出,港股创新药ETF(159567)跟踪指数走势较强,云顶新耀-B、来凯医药-B、翰森制药领涨。
翰森制药午后涨近4% 美银证券将目标价调高26.8%至20.8港元
新浪港股 · 06-25
翰森制药午后涨近4% 美银证券将目标价调高26.8%至20.8港元
港股异动 | 翰森制药(03692)涨超3% 美银指其创新药物开发以及商业化方面取得扎实进展
智通财经 · 06-25
港股异动 | 翰森制药(03692)涨超3% 美银指其创新药物开发以及商业化方面取得扎实进展
创新药有望加速进院,港股创新药ETF(159567)跟踪指数大幅上涨,复星医药、云顶新耀-B、翰森制药领涨。
有连云 · 06-25
创新药有望加速进院,港股创新药ETF(159567)跟踪指数大幅上涨,复星医药、云顶新耀-B、翰森制药领涨。
键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户
每日经济新闻 · 06-24
键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户
翰森制药盘中异动 下午盘股价大跌5.08%报16.441港元
自选股智能写手 · 06-20
翰森制药盘中异动 下午盘股价大跌5.08%报16.441港元
翰森制药(03692)股价下跌5.081%,现价港币$16.44
阿斯达克财经 · 06-20
翰森制药(03692)股价下跌5.081%,现价港币$16.44
加载更多
公司概况
公司名称:
翰森制药
所属市场:
SEHK
上市日期:
--
主营业务:
翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。该公司的主要产品包括欧兰宁、阿美宁、普来乐、泽菲、昕维、昕美、泽坦、迈灵达、恒捷、恒森、孚来迪和瑞波特等。该公司产品主要用于中枢神经系统疾病、抗肿瘤、抗感染、糖尿病、消化道和心血管治疗。该公司主要在中国内地销售产品。
发行价格:
--
{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":17.78,"timestamp":1721635736031,"preClose":17.28,"halted":0,"volume":2992196,"delay":0,"floatShares":5935650070,"shares":5935650070,"eps":0.5920349,"marketStatus":"未开盘","marketStatusCode":0,"change":0.5,"latestTime":"07-22 16:08:56","open":17.5,"high":18,"low":17.36,"amount":53033448,"amplitude":0.037037,"askPrice":17.8,"askSize":196000,"bidPrice":17.78,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.5592905786671247,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1560441600000,"adjPreClose":17.28,"dividendRate":0.011652,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.887501,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2453817547","title":"港股异动 | 翰森制药(03692)涨逾3% 阿美乐肺癌辅助治疗适应症国内上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2453817547","media":"智通财经","labels":["Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2453817547?lang=zh_cn&edition=full","pubTime":"2024-07-22 11:11","pubTimestamp":1721617871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,翰森制药(03692)涨逾3%,截至发稿,涨3.24%,报17.80港元,成交额2377.71万港元。消息面上,近日,翰森制药发布公告,由公司附属公司江苏豪森药业集团有限公司开发的1类创新药阿美乐用于具有表皮生长因数受体(EGFR)外显子19缺失或外显子21(L858R)置换突变阳性的非小细胞肺癌(NSCLC)成人患者肿瘤切除术后的辅助治疗的上市许可申请,获中华人民共和国国家药品监督管理局受理。此次申请为阿美乐第三个适应症。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","BK1589","HSCEI","YANG","BK1191","HSTECH","BK1583"],"gpt_icon":1},{"id":"2452441535","title":"翰森制药(03692):阿美乐®用于EGFR突变阳性辅助治疗非小细胞肺癌上市许可申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2452441535","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452441535?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:36","pubTimestamp":1721378183,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药 发布公告,由公司附属公司江苏豪森药业集团有限公司开发的1类创新药阿美乐用于具有表皮生长因数受体外显子19缺失或外显子21置换突变阳性的非小细胞肺癌成人患者肿瘤切除术后的辅助治疗的上市许可申请,获中华人民共和国国家药品监督管理局受理。2020年获批用于既往经EGFR-TKI治疗进展,且T790M突变阳性的局部晚期或转移性NSCLC患者,并已于2023年1月成功续约继续录入2022年国家医保目录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2452410864","title":"翰森制药(03692.HK):阿美乐用于辅助治疗非小细胞肺癌上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2452410864","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452410864?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:34","pubTimestamp":1721378040,"startTime":"0","endTime":"0","summary":"翰森制药(03692.HK) 公布,附属江苏豪森药业开发的1类创新药阿美乐用于具有表皮生长因数受体(EGFR)外显子19缺失或外显子21(L858R)置换突变阳性的非小细胞肺癌(NSCLC)成人患者肿瘤切除术后的辅助治疗的上市许可申请,获国家药监局受理。此次申请为阿美乐第三个适应症。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-07-19 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20201021164016783_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20201021164016783_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1364977/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1191","BK1589","03692"],"gpt_icon":0},{"id":"2452449138","title":"翰森制药07月19日主力资金流出172万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2452449138","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452449138?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:15","pubTimestamp":1721376945,"startTime":"0","endTime":"0","summary":"07月19日, 翰森制药股价跌0.35%,报收17.28元,成交金额6607万元,换手率0.06%,振幅2.42%,量比1.13。翰森制药今日主力资金净流出172万元,连续3日净流出,上一交易日主力净流出239万元,今日环比减少28.03%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为100.00%,平均跌幅为2.39%。该股近5个交易日上涨2.98%,主力资金累计净流入134万元;近20日主力资金累计净流入178万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916162595db84f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916162595db84f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2452171782","title":"翰森制药07月18日遭主力抛售239万元 环比增加895.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452171782","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452171782?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:15","pubTimestamp":1721290526,"startTime":"0","endTime":"0","summary":"07月18日, 翰森制药股价涨0.58%,报收17.34元,成交金额5591万元,换手率0.05%,振幅2.67%,量比0.99。翰森制药今日主力资金净流出239万元,上一交易日主力净流出24万元,今日环比增加895.83%。该股近5个交易日上涨8.86%,主力资金累计净流入305万元;近20日主力资金累计净流入349万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816153695d42bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816153695d42bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2452497911","title":"南向资金7月16日净买入翰森制药100.00万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452497911","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452497911?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:31","pubTimestamp":1721179889,"startTime":"0","endTime":"0","summary":"7月16日, 南向资金增持翰森制药100.00万股,连续3日增持。截止当日收盘,港股通共持有翰森制药16126.51万股,占流通股2.70%。翰森制药近5个交易日上涨3.25%,港股通累计增持25.40万股;近20个交易日下跌5.61%,港股通累计减持110.13万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170946419f5a2474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170946419f5a2474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2451937506","title":"翰森制药(03692)出现大手成交130万股,成交价$16.55,涉资2.152千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2451937506","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451937506?lang=zh_cn&edition=full","pubTime":"2024-07-16 13:24","pubTimestamp":1721107440,"startTime":"0","endTime":"0","summary":"[大手成交]翰森制药(03692)在下午01:24出现大手成交,成交量为130万,成交价为港币$16.55,涉资2.152千万。至目前为止,股价升0.486%,今日最高价为$16.76,而最低价为$16.24,总成交量为287.363万股,总成交金额港币$4.762千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2407163749/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2449749941","title":"翰森制药(03692)下跌5.17%,报15.78元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449749941","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449749941?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:22","pubTimestamp":1720419723,"startTime":"0","endTime":"0","summary":"7月8日,翰森制药(03692)盘中下跌5.17%,截至14:22,报15.78元/股,成交6286.77万元。翰森制药集团有限公司是中国规模最大、增长最快的研发驱动型制药公司之一,主要在中枢神经系统、抗肿瘤、抗感染和糖尿病等治疗领域确立了领先地位。同时,该公司也在消化道和心血管治疗领域进行了深入研究和开发。截至2023年年报,翰森制药营业总收入101.04亿元、净利润32.78亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/08142241427894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"2449490749","title":"翰森制药盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449490749","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449490749?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:22","pubTimestamp":1720419722,"startTime":"0","endTime":"0","summary":"2024年07月08日下午盘14时22分,翰森制药股票出现异动,股价快速下挫5.17%。截至发稿,该股报15.780港元/股,成交量384.8万股,换手率0.06%,振幅5.65%。资金方面,该股资金流入1139.45万港元,流出1793.33万港元。翰森制药股票所在的药品行业中,整体跌幅为0.57%。翰森制药公司简介:翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081422029681a91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081422029681a91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2448847621","title":"翰森制药07月02日遭主力抛售106万元 环比增加1666.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448847621","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448847621?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:15","pubTimestamp":1719908121,"startTime":"0","endTime":"0","summary":"07月02日, 翰森制药股价跌2.70%,报收15.88元,成交金额4494万元,换手率0.05%,振幅4.41%,量比0.98。翰森制药今日主力资金净流出106万元,上一交易日主力净流出6万元,今日环比增加1666.67%。该股近5个交易日下跌1.12%,主力资金累计净流出218万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入2318万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702161531956522f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702161531956522f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1191","03692","BK1583"],"gpt_icon":0},{"id":"2446818559","title":"翰森制药(03692)根据获采纳首次公开发售后受限制股份单位计划授出合共代表1139.76万股的受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2446818559","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446818559?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:33","pubTimestamp":1719498787,"startTime":"0","endTime":"0","summary":"翰森制药(03692)发布公告,于2024年6月27日,根据公司于2019年5月2...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_30.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03692","BK1583","BK1589","BK1191"],"gpt_icon":0},{"id":"2446471897","title":"更新版 1-诺和诺德的司美格鲁肽在中国获准“名正言顺”用来减肥,A股概念股逆市上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=2446471897","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446471897?lang=zh_cn&edition=full","pubTime":"2024-06-25 17:39","pubTimestamp":1719308396,"startTime":"0","endTime":"0","summary":" 路透上海6月25日 - 丹麦诺和诺德 的司美格鲁肽号称“减肥神药”,在爱美人士中走红。现在这款药物终于在中国原研专利到期前,被批准用于治疗超重和肥胖症。这意味着中国也成为继日本之后,第二个批准诺和诺德的司美格鲁肽治疗肥胖的亚洲国家。诺和诺德大中国区高管在3月表示,在中国推出的用于减肥的司美格鲁肽最开始将以自费患者为主。诺和诺德的司美格鲁肽在中国的专利将于2026年3月20日到期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","300199","BK0183","BK4534","IE0002141913.USD","LU1988902786.USD","LU1551013342.USD","LU2491049909.HKD","LU1804176565.USD","LU2148510915.USD","IE0004445239.USD","LU0882574055.USD","LU0122379950.USD","GB00BDT5M118.USD","01801","LU2237438978.USD","LU2264538146.SGD","LU1064130708.USD","LLY","LU1280957306.USD","LU1814569148.SGD","399300","LU1057294990.SGD","LU0289739699.SGD","BK4533","BK0077","BK4007","LU0109391861.USD","LU2468319806.SGD","LU0672654240.SGD","BK0070","159982","000963","BK0175","IE00B1BXHZ80.USD","BK0239","LU1551013425.SGD","BK1589","LU1023059063.AUD","300122","LU0256863811.USD","LU0417517546.SGD","LU0058720904.USD","LU0708995401.HKD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU0079474960.USD","LU0061475181.USD","IE00BJJMRZ35.SGD","03692"],"gpt_icon":0},{"id":"2446867585","title":"港股估值性价比凸显,恒生港股通ETF(159318)跟踪指数大幅上涨,蒙牛乳业、翰森制药、龙湖集团领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446867585","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446867585?lang=zh_cn&edition=full","pubTime":"2024-06-25 14:51","pubTimestamp":1719298316,"startTime":"0","endTime":"0","summary":"2024年6月25日,恒生指数的“港股通“版本——恒指港股通指数走势较强。盘面上,蒙牛乳业领涨,翰森制药、龙湖集团跟涨,恒生港股通ETF(159318)市场热度较高,实时成交额已突破1482万元。天风证券表示,截至2024年6月16日,港股总回购金额已达1147.7亿港元,有望打破2023年1269.4亿港元的年度回购记录。宏观层面来看,5月份,社会消费品零售总额39211亿元,同比增长3.7%,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406251452019f62cd8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406251452019f62cd8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0471298777.SGD","LU0287142896.SGD","LU1102505762.USD","LU1439103000.SGD","HSCEI","LU2125910500.SGD","LU0251143458.SGD","LU0211977185.USD","BK1555","BK1240","LU1048588211.SGD","LU0672654166.SGD","LU1515016050.SGD","LU0594300419.USD","LU0106959298.USD","LU0326950275.SGD","LU0651946864.USD","BK1597","LU0359202008.SGD","03692","HSTECH","LU0359201612.USD","LU0029875118.USD","BK1589","LU1023057109.AUD","LU0307460666.USD","LU0823426308.USD","LU0048580855.USD","LU0543330483.HKD","BK1191","IE0008368742.USD","LU0588546209.SGD","LU0348788117.USD","BK1521","LU1051768304.USD","BK1553","BK1583","SG9999002828.SGD","LU0385154629.USD","LU0320764755.SGD","07226","LU2045819591.USD","BK1237","LU0228659784.USD","00960","02319","LU0315179316.USD","LU0072462343.USD","LU0128522157.USD","LU0370786039.SGD"],"gpt_icon":0},{"id":"2446277861","title":"创新药板块催化频出,港股创新药ETF(159567)跟踪指数走势较强,云顶新耀-B、来凯医药-B、翰森制药领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446277861","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446277861?lang=zh_cn&edition=full","pubTime":"2024-06-25 14:21","pubTimestamp":1719296513,"startTime":"0","endTime":"0","summary":"2024年6月25日,港股创新药板块走势占优。盘面上,云顶新耀-B领涨,来凯医药-B、翰森制药跟涨,港股创新药ETF市场热度较高,过去5个交易日日均成交额6447万元。受益于个股业绩超预期海内外新药研发数据优秀等利好催化,减重药、艾滋病预防用药、脑机接口等热点主题表现相对活跃。当前医药生物板块整体表现持续低迷,市场情绪有待恢复,建议以中长线视角布局高景气细分领域投资机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062514215595d55b32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062514215595d55b32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03692","02105","BK1583","BK1161","01952","BK1589","06978","BK1191"],"gpt_icon":0},{"id":"2446586590","title":"翰森制药午后涨近4% 美银证券将目标价调高26.8%至20.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446586590","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446586590?lang=zh_cn&edition=full","pubTime":"2024-06-25 13:18","pubTimestamp":1719292722,"startTime":"0","endTime":"0","summary":"翰森制药午后上涨3.62%,现报16.62港元,成交额2364.95万港元。 此前,美银证券发布研究报告称,将翰森制药目标价由16.4港元调高26.8%至20.8港元,同时将投资评级从“跑输大市”上调至“买入”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-25/doc-inazxpep7061217.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-06-25/doc-inazxpep7061217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["03692"],"gpt_icon":0},{"id":"2446528458","title":"港股异动 | 翰森制药(03692)涨超3% 美银指其创新药物开发以及商业化方面取得扎实进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2446528458","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446528458?lang=zh_cn&edition=full","pubTime":"2024-06-25 11:30","pubTimestamp":1719286236,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,翰森制药涨超3%,截至发稿,涨3.24%,报16.56港元,成交额2052.48万港元。美银此前发布研报指出,创新药成为翰森制药的主要收入贡献者。去年公司新药及合作产品收入同比增37.1%至69亿元,高于其他大型制药厂,这意味着创新药物开发以及商业化方面取得扎实进展。创新药政策支持以及VBP实施,极大地限制仿制药市场,预计创新药将继续成为医药行业的主要成长动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","07226","159992","06978","BK1589","YANG","BK1583","BK1191","HSTECH","BK1574","BK1161","HSCEI"],"gpt_icon":0},{"id":"2446550038","title":"创新药有望加速进院,港股创新药ETF(159567)跟踪指数大幅上涨,复星医药、云顶新耀-B、翰森制药领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446550038","media":"有连云","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446550038?lang=zh_cn&edition=full","pubTime":"2024-06-25 10:22","pubTimestamp":1719282126,"startTime":"0","endTime":"0","summary":"2024年6月25日,港股创新药板块走势占优。此举标志着广东省在深化医疗保障制度改革、优化药品供应保障体系方面迈出了新的一步。此措施有助于进一步规范药品市场,保障公众用药需求,提高药品可及性、促进创新药行业健康发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062510221095d4b7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062510221095d4b7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1589","BK1161","01952","600196","02196","BK1515","06978","BK1583","BK1574","BK1593"],"gpt_icon":0},{"id":"2445047074","title":"键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047074","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047074?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:31","pubTimestamp":1719217878,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问 信达生物、翰森制药与贵公司有合作吗?键凯科技(688356.SH)6月24日在投资者互动平台表示,翰森制药子公司江苏豪森药业集团有限公司是公司客户,与该客户的合作情况请参见招股说明书、定期报告的公开披露情况。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416314095d1c899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416314095d1c899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK0229","688356"],"gpt_icon":0},{"id":"2444266622","title":"翰森制药盘中异动 下午盘股价大跌5.08%报16.441港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444266622","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444266622?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:12","pubTimestamp":1718867526,"startTime":"0","endTime":"0","summary":"2024年06月20日下午盘15时12分,翰森制药股票出现异动,股价快速下跌5.08%。截至发稿,该股报16.441港元/股,成交量258.4万股,换手率0.04%,振幅4.85%。资金方面,该股资金流入1517.93万港元,流出2312.18万港元。机构评级方面,在所有19家参与评级的机构中,89%的券商给予买入建议,11%的券商给予持有建议,无券商给予卖出建议。翰森制药股票所在的药品行业中,整体跌幅为0.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201512069681575b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201512069681575b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1589","03692"],"gpt_icon":0},{"id":"2444326659","title":"翰森制药(03692)股价下跌5.081%,现价港币$16.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2444326659","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444326659?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:12","pubTimestamp":1718867520,"startTime":"0","endTime":"0","summary":"[下跌股]翰森制药(03692) 股价在下午03:12比前收市价下跌5.081%,现股价为港币$16.44。至目前为止,今日最高价为$17.28,而最低价为$16.44。总成交量为258.4万股,总成交金额为港币$4.315千万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406201218/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0802},{"period":"1month","weight":0.0895},{"period":"3month","weight":0.0881},{"period":"6month","weight":0.455},{"period":"1year","weight":0.4613},{"period":"ytd","weight":0.1282}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。该公司的主要产品包括欧兰宁、阿美宁、普来乐、泽菲、昕维、昕美、泽坦、迈灵达、恒捷、恒森、孚来迪和瑞波特等。该公司产品主要用于中枢神经系统疾病、抗肿瘤、抗感染、糖尿病、消化道和心血管治疗。该公司主要在中国内地销售产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.024511},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000669},{"month":3,"riseRate":0.2,"avgChangeRate":-0.042173},{"month":4,"riseRate":0.6,"avgChangeRate":0.041694},{"month":5,"riseRate":0.6,"avgChangeRate":0.008689},{"month":6,"riseRate":0.6,"avgChangeRate":0.036568},{"month":7,"riseRate":0.5,"avgChangeRate":-0.025494},{"month":8,"riseRate":0.6,"avgChangeRate":-0.010974},{"month":9,"riseRate":0.4,"avgChangeRate":-0.05981},{"month":10,"riseRate":0.2,"avgChangeRate":0.031364},{"month":11,"riseRate":0.6,"avgChangeRate":0.050363},{"month":12,"riseRate":0.8,"avgChangeRate":0.06514}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}